Gsk (GLAXF) Return on Sales (2009 - 2026)

Gsk's Return on Sales history runs 18 years deep, the most recent figure standing at 0.0% for Q1 2026.

• In Q1 2026, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed N/A from the prior year.
• Return on Sales was 0.0% for Q1 2026 at Gsk, up from 0.0% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.01% in Q3 2022 to a low of 0.0% in Q3 2024.
• Historically, Return on Sales has averaged 0.0% across 5 years, with a median of 0.0% in 2023.
• The sharpest annual moves came in 2022 and 2023: Return on Sales gained 1 bps in 2022, then slipped 1 bps in 2023.
• A 5-year view of Return on Sales shows it stood at 0.0% in 2022, then jumped by 643 bps to 0.0% in 2023, then slumped by 33 bps to 0.0% in 2024, then advanced by 8 bps to 0.0% in 2025, then surged by 34 bps to 0.0% in 2026.
• The last three Return on Sales figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.